Curebase

San Francisco, United States Founded: 2017 • Age: 9 yrs
Patient enrollment platform for decentralized clinical research is provided.

About Curebase

Curebase is a Healthcare company based in San Francisco (United States) founded in 2017. Patient enrollment platform for decentralized clinical research is provided. Curebase has raised $59.01 million across 4 funding rounds from investors including Gilead, Industry Ventures and Acrew Capital. Its chief executive, as recorded, is Storm Stillman. Its website curebase.com draws about 44 thousand monthly visits. Curebase offers products and services including ePRO/eCOA, eConsent, Unified Participant Experience, and EDC. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is CUREBASE, INC. Its competitors include L7 Informatics, Clinical Research IO and THREAD; 3 of its 3 listed competitors have raised funding.

Company details

Curebase was founded in 2017 in San Francisco, United States, within the clinical research sector. A platform is operated to facilitate patient enrollment and engagement for decentralized trials. Eligibility screening, enrollment processes, participant education, and consent management are streamlined. In-app guidance on protocols is delivered to users, alongside capabilities for document scanning and upload. Operations focus on enhancing trial conduction efficiency.

  • Headquarters San Francisco, United States
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website curebase.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Curebase, Inc.
Key Metrics
  • Total Equity Funding
    $59.01M (USD)

    in 4 rounds

  • Latest Funding Round
    $40M (USD), Series B

    May 2022

  • Investors
    Gilead

    & 9 more

Products & Services of Curebase

Curebase offers a comprehensive portfolio of products and services, including ePRO/eCOA, eConsent, Unified Participant Experience, and EDC.

ePRO/eCOA
eClinical Software

Tools for electronic patient-reported outcomes in clinical trials.

eConsent
Consent Management

Platform for paperless consent in multi-device clinical studies.

Unified Participant Experience
Participant Engagement

Integrated mobile system for study prescreening and data submission.

EDC
Data Collection

Unified platform for hybrid study data management and monitoring.

Apps and channels of Curebase

Curebase publishes 1 mobile app with over 1K+ downloads; its YouTube channel Curebase has 3 subscribers and 2 videos.

Walgreens Clinical Trials
Google Play Health & Fitness Everyone Free 1K+ downloads
Developer: Curebase
View on Google Play
Curebase
YouTube 3 subscribers 2 videos Howto & Style
Open channel

Videos from Curebase

The most watched videos on Curebase's YouTube channel, Curebase (3 subscribers). Click a video to play it here.

Curebase’s Study Designer
36 views
Challenges & Solutions Designing ePRO and eConsent for Pediatric Trials
23 views

More on Curebase.

Funding Insights of Curebase

Curebase has successfully raised a total of $59.01M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $40 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $59.01M
  • Total Rounds 4
  • Last Round Series B — $40M
  • First Round $150,000

    (Aug 2018)

  • Investors Count 10

All 4 funding rounds of Curebase with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022$40MSeries B–Industry Ventures
Apr 2021$16.35MSeries A–GGV Capital
Oct 2018$2.51MSeries A––
–
Aug 2018$150,000Seed––
Valuation history

10 investors in total: 10 institutional.

Investors in Curebase

Curebase has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Gilead, Industry Ventures and Acrew Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments in private tech ecosystem are made by Industry Ventures.
industryventures.comSan Francisco, United States
Early-stage startups are funded by Acrew Capital venture firm.
acrewcapital.comPalo Alto, United States
Venture capital firm focused on SaaS, mobile tech, AI, and multiple sectors
wilab.comPalo Alto, United States
Venture capital firm investing in early stage and later stage gaming companies
positivesumvc.comSeattle, United States
Venture capital investing with a focus on diversity and inclusion in the ecosystem.
gaingels.com
Early-stage life sciences and tech focused VC firm investing primarily in the US
boldcapitalpartners.comSanta Monica, United States
Early-stage venture capital funding is provided by Xfund.
xfund.comCambridge, United States
Venture capital is invested in cybersecurity, fintech, and AI startups.
ggvc.comMenlo Park, United States
Early-stage startups are accelerated via funding and educational programs.
ycombinator.comMountain View, United States
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987gilead.comFoster City, United States
Premium access

Investor details for Curebase

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Curebase

24 people are tracked at Curebase (5 in leadership, 19 in team).

NameRoleGroup
Storm Stillman
CEOLeadership
Sherry Jones
Vice President, QualityLeadership
Scott Garcia
Chief Financial OfficerLeadership
Cori Davis
Head of Customer SuccessLeadership
Patrick Austermann
Vice President of Engineering and ProductLeadership
Graham Carney
Board ObserverTeam
Jeff Richards
Board Member, Venture InvestorTeam
Noah Debrincat
Lead Product ManagerTeam
Ignacio Arana
Sr QA EngineerTeam
Gaspar Neto
Senior Software EngineerTeam
Jane Myles
Strategic AdvisorTeam
Amir Lahav
Asvisory Board MemberTeam
Angelica Artocilla
Clinical Research Coordinator IITeam
David Alejandro Ochoa Reyes
Sr. Software EngineerTeam
Lars-Olof Eriksson
Strategic AdvisorTeam
Lucas del Yerro
Senior Test Automation Engineer | Tech LeadTeam
Julie Ann Camino
Clinical Research CoordinatorTeam
Sarah R.
Customer Success ManagerTeam
João Mainka
Staff EngineerTeam
Janely Pichardo
Associate, Clinical Project ManagerTeam

4 more people are available in the full profile.

Premium access

Complete people profiles for Curebase

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Curebase

3 dated milestones of Curebase across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Curebase is founded.
  2. Funding First funding round of $150K.
  3. Funding Latest funding round, Series B, of $40.0M.

Competitors of Curebase

Curebase has 3 listed competitors in our database, 3 of them funded. They include L7 Informatics, Clinical Research IO and THREAD.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
l7informatics.com2012Austin, United States$54.97M126
Clinical trial workflow management software is provided for laboratories.
clinicalresearch.io2015Boston, United States$16.7M16
Clinical trial management software is provided for research sites.
threadresearch.com2012Tustin, United States$50M7
Provider of patient research studies software
Premium access

Detailed competitors of Curebase

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Curebase

The website of Curebase (curebase.com) receives about 44.3K visits a month.

  • Monthly visits
    44.3K

    ▲ 17.2% vs previous month

Similar websites

Websites whose visitors overlap most with Curebase. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
facebook.com
100%
12.1B#3View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Curebase (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Curebase

Premium access

Complete news archive for Curebase

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Curebase

Curebase was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Curebase is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Storm Stillman is the CEO of Curebase, as recorded in our data.

Curebase is a funded company, having raised a total of $59.01M across 4 funding rounds to date. The company's 1st funding round was a Seed of $150K, raised on Aug 2018.

Curebase was founded in 2017 in San Francisco, United States, within the clinical research sector. A platform is operated to facilitate patient enrollment and engagement for decentralized trials. Eligibility screening, enrollment processes, participant education, and consent management are streamlined. In-app guidance on protocols is delivered to users, alongside capabilities for document scanning and upload. Operations focus on enhancing trial conduction efficiency.

Curebase's top competitors include L7 Informatics, Clinical Research IO and THREAD.

Curebase offers ePRO/eCOA, eConsent, Unified Participant Experience, and EDC.

Curebase has 10 investors. Key investors include Gilead, Industry Ventures, Acrew Capital, World Innovation Lab, and Positive Sum.

Curebase operates through Curebase, Inc..

Yes. Curebase publishes Walgreens Clinical Trials, with over 1,000 downloads.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available